MedTrace Logo

Laser Therapy for Treatment of Urogenital Symptoms in Women

NCT03681678 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-12-23

Study results available
· View outcomes & findings →

Summary

This is a prospective observational study of women undergoing vaginal treatment with the fractional carbon dioxide (fCO2) laser for various urogenital symptoms.

Conditions

Interventions

DEVICE

fCO2 Laser Therapy Group

Women enrolled in the study will receive three treatments with the fractional carbon dioxide (fCO2) laser. The interval between treatments is approximately six weeks. Intra-vaginal laser treatments will be delivered at 8 points at each level of the vaginal wall.

Sponsors & Collaborators

  • Corewell Health East

    lead OTHER

Principal Investigators

  • Kenneth Peters, MD · Corewell Health William Beaumont University Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-08
Primary Completion
2022-12-15
Completion
2025-06-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03681678 on ClinicalTrials.gov